Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status-Reference-Cited by-同舟云学术

Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status

Published:2023-04-01 Issue:4 Volume:26 Page:548-553
ISSN:1096-6218
Container-title:Journal of Palliative Medicine
language:en
Short-container-title:Journal of Palliative Medicine

Author:

Fujita Yukiyoshi¹,Imai Hisao²³^ORCID,Hiruta Eriko¹,Masuno Takashi⁴,Yamazaki Shigeki⁵,Tanaka Hajime⁶,Kamiya Teruhiko⁷,Sandoh Mitsuru⁸,Takei Satoshi⁹,Arai Kazuya¹⁰,Nishiba Hiromi¹¹¹²,Mogi Junnosuke¹³,Koizuka Shiro¹⁴,Saito Taeko¹,Obayashi Kyoko¹²,Kaira Kyoichi³,Minato Koichi²

Affiliation:

1. Divisions of Pharmacy, Gunma Prefectural Cancer Center, Ota, Japan.

2. Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Japan.

3. Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Japan.

4. Division of Pharmacy, Fujioka General Hospital, Fujioka, Japan.

5. Division of Pharmacy, Kiryu Kosei General Hospital, Kiryu, Japan.

6. Division of Pharmacy, Haramachi Red Cross Hospital, Agatsuma-gun, Japan.

7. Department of Pharmacy, Tatebayashi Kosei General Hospital, Tatebayashi, Japan.

8. Division of Pharmacy, Ota Memorial Hospital, Ota, Japan.

9. Division of Pharmacy, Tone Central Hospital, Numata, Japan.

10. Division of Pharmacy, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.

11. Division of Pharmacy, Japan Community Health Care Organization (JCHO) Gunma Chuo Hospital, Maebashi, Japan.